Protillion Biosciences: Raises $18M in Series A Financing

Protillion Biosciences Raises $18M in Series A Financing

• Protillion Biosciences, a Burlingame, CA-based biotech company, raised $18M in Series A funding
• The round was led by ARCH Venture Partners and Illumina Ventures
• The company intends to use the funds to scale its hardware infrastructure and development teams
• ProtillionBiosciences is a Stanford University spinout commercializing technology for therapeutic antibody and binder discovery
• The company’s platform enables its commercial drug discovery partners to perform quantitative analysis on complete protein libraries, producing actionable insights in days